Abstract
5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
Q Jiang, A Sebastian, S Archer and J M Bidlack
Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1107-1113;